This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Bruker Corporation's Management Presents At Goldman Sachs Healthcare Conference - Conference Call Transcript

Bruker Corporation (BRKR)

Goldman Sachs Healthcare Conference

June 5, 2012 5:00 p.m. EDT


Isaac Ro – Goldman Sachs, Analyst

Stacey Desrochers – Burker Corporation, IR Director


No Analysts


Isaac Ro

Okay, let’s get started here. Thanks for joining us here after lunch. I'm Isaac Ro, analyst here at Goldman. And I'm happy to have Stacey Desrochers from Bruker here to talk about the company.

And for those of you who are not familiar, the company has actually had a very busy start to the summer here. You had a big showing at the ASMS Conference. You had your first-ever investor meeting last week in New York. So there’s a lot of new stuff going on, and the stock’s had a pretty good run here with lots of improvements to the franchise over the last couple of years.

So, certainly, happy to take any questions throughout the course of the next 30 or 40 minutes. If you have them, please just raise your hand.

And with that as backdrop, let me just start by saying, thanks for coming, and feel free to give us a couple minutes update for the takeaways on the analyst meeting, if you like, and the key areas of focus for the balance of the year.

Stacey Desrochers

So, Bruker Corporation is a life science tools company. As Isaac said, we had our first Analyst Day ever last Friday in New York. It was well-attended, webcast and out there for folks if you want to listen to it. But we highlighted technologies and the new businesses that we acquired in 2010.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.02 0.00%
FB $104.07 0.00%
GOOG $683.57 0.00%
TSLA $162.60 0.00%
YHOO $27.97 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs